U.P. Oncolytics
PrivateLast Round
Grant
Jan 7, 2026
Total Funding Raised
$650,000
Momentum Score
25 /100
Company Overview
U.P. Oncolytics is a biotechnology company that develops oncolytic virus treatments for rare and resistant cancers like glioblastoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
U.P. Oncolytics Comps
Public and private peers based on sector, stage, and business model.
U.P. Oncolytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 7, 2026 | ||||
| Grant | Jun 25, 2025 | ||||
| Grant | Sep 30, 2024 |
Key People
Founding team and executive leadership
U.P. Oncolytics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 2778% MoM, from 9 to 259.
- Jan 7, 2026
$75K grant from Illinois Department of Commerce and Economic Opportunity.
U.P. Oncolytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about U.P. Oncolytics's valuation, stock price, and market status.
